JZP-541
N/A
Report date: 2025/04/30 20:00:42
NME
Base Information
Drug NameJZP-541
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGw Pharmaceuticals Plc
China Registration ClassN/A
Develop Information
Active CompaniesWeston Brain Institute
Inactive CompaniesGw Research LtdJazz Pharmaceuticals Plc
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A